Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P0
Near historical low
Average
1.56
Historical baseline
PeriodValueYoY Change
20250.00-
20240.00-100.0%
20237.79-
20220.00-
20210.00-